Integral Health Asset Management, LLC Crispr Therapeutics Ag Transaction History
Integral Health Asset Management, LLC
- $1.04 Billion
- Q2 2024
A detailed history of Integral Health Asset Management, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 150,000 shares of CRSP stock, worth $7.1 Million. This represents 0.78% of its overall portfolio holdings.
Number of Shares
150,000
Previous 220,000
31.82%
Holding current value
$7.1 Million
Previous $15 Million
45.98%
% of portfolio
0.78%
Previous 1.42%
Shares
7 transactions
Others Institutions Holding CRSP
# of Institutions
523Shares Held
58MCall Options Held
1.73MPut Options Held
1.84M-
Capital International Investors Los Angeles, CA7.87MShares$372 Million0.09% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.78MShares$368 Million3.82% of portfolio
-
Nikko Asset Management Americas, Inc.3.15MShares$149 Million1.99% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.3.15MShares$149 Million0.13% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$131 Million0.0% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.69B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....